Synthesis and biological evaluation of epothilone A dimeric compounds

Bioorganic & Medicinal Chemistry
2009.0

Abstract

The preparation and biological evaluation of a novel series of dimeric epothilone A derivatives (1-6) are described. Two types of diacyl spacers were introduced to establish the various dimeric epothilone A constructs. The effect of these compounds on tubulin polymerization and their cytotoxicity against four different cancer cell lines are reported. Several of the newly synthesized compounds inhibit endothelial cell differentiation and endothelial cell migration that are key steps of the angiogenic process.

Knowledge Graph

Similar Paper

Synthesis and biological evaluation of epothilone A dimeric compounds
Bioorganic & Medicinal Chemistry 2009.0
Synthesis and SAR of C12–C13-oxazoline derivatives of epothilone A
Bioorganic & Medicinal Chemistry Letters 2009.0
Synthesis and biological evaluation of 4-aza-2,3-dihydropyridophenanthrolines as tubulin polymerization inhibitors
Bioorganic & Medicinal Chemistry Letters 2014.0
Inhibitors of tubulin polymerization: Synthesis and biological evaluation of hybrids of vindoline, anhydrovinblastine and vinorelbine with thiocolchicine, podophyllotoxin and baccatin III
Bioorganic & Medicinal Chemistry 2008.0
Synthesis and evaluation of daunorubicin-paclitaxel dimers
Bioorganic & Medicinal Chemistry Letters 2000.0
Synthesis and biological evaluation of highly potent analogues of epothilones B and D
Bioorganic & Medicinal Chemistry Letters 2000.0
Design, synthesis and biological evaluation of millepachine derivatives as a new class of tubulin polymerization inhibitors
Bioorganic & Medicinal Chemistry 2013.0
Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors
European Journal of Medicinal Chemistry 2021.0
Synthesis and biological evaluation of new camptothecin derivatives obtained by modification of position 20
Bioorganic & Medicinal Chemistry 2010.0
Synthesis and biological evaluation of novel anticancer bivalent colchicine–tubulizine hybrids
Bioorganic & Medicinal Chemistry 2012.0